Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,820,871
-
Share change
-
+1,176,875
-
Total reported value
-
$50,656,070
-
Put/Call ratio
-
191%
-
Price per share
-
$2.84
-
Number of holders
-
87
-
Value change
-
+$3,312,296
-
Number of buys
-
43
-
Number of sells
-
23
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2023
As of 31 Dec 2023,
Humacyte, Inc. - COM (HUMA) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,820,871 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, Prescott General Partners LLC, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, GSA CAPITAL PARTNERS LLP, and LPL Financial LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.